Yu Jiaping_Suzhou MyLike Plastic and Cosmetic Hospital Comprehensive Expert in Double Eyelid Surgery, Rhinoplasty, Facial Contouring, Breast Surgery, Liposuction and Weight Loss
Yu Jiaping works at Suzhou Meilai Plastic and Cosmetic Hospital and specializes in double eyelid surgery, rhinoplasty, facial contouring, breast plastic surgery, liposuction, minimally invasive wrinkle removal, and various plastic and cosmetic surgeries,

Yu Jiaping
President of Mylike Plastic and Aesthetic Center
Chinese Director of Mylike (Suzhou) Beauty Hospital
Chief Physician of Plastic and Aesthetic Surgery, Mylike Beauty Hospital
Council Member of the Chinese Branch of the Society of Facial Plastic and Reconstructive Surgery
Member of the Plastic Surgery Committee of the Zhejiang Medical Association
Standing Committee Member of the Medical Aesthetics Committee of the Zhejiang Medical Association
Member of the Burn and Plastic Surgery Committee of the Nanjing Military Region
Editorial Board Member of Chinese Journal of Clinical Medicine
Adjunct Professor at Shanghai Second Military Medical University
Specialties
Double eyelid surgery, rhinoplasty, facial contouring, breast plastic surgery, liposuction for fat reduction, minimally invasive wrinkle removal, and various other plastic and aesthetic surgeries. Three-dimensional facial contour remodeling, minimally invasive wrinkle removal, and other surgical methods have received extensive recognition and acclaim in the industry.
Honors and Achievements
He formerly served as Director of the Plastic and Aesthetic Surgery Center of the 98th Hospital of the PLA Nanjing Military Region, Professor at Shanghai Second Military Medical University and Nanchang University in Jiangxi, and Visiting Professor at the Korean Association of Plastic Surgeons. He has published dozens of papers in numerous domestic and international medical journals and was honorably invited to serve as an editorial board member of Chinese Journal of Clinical Medicine.
Leave your information for a 1-on-1 private consultation.